On 2025-05-12, Bolt Biotherapeutics, Inc. (BOLT) announced earnings per share of $-0.29 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.34.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.32 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-12 | 2025-03-31 | $-0.34 | $-0.29 |
| 2025-03-24 | 2024-12-31 | $-0.38 | $-0.38 |
| 2024-11-12 | 2024-09-30 | $-0.36 | $-0.40 |
| 2024-08-13 | 2024-06-30 | $-0.54 | $-0.56 |
| 2024-05-14 | 2024-03-31 | $-0.51 | $-0.28 |
| 2024-03-21 | 2023-12-31 | $-0.47 | $-0.47 |
| 2023-11-09 | 2023-09-30 | $-0.49 | $-0.43 |
| 2023-08-07 | 2023-06-30 | $-0.53 | $-0.48 |
| 2023-05-11 | 2023-03-31 | $-0.49 | $-0.45 |
| 2023-03-29 | 2022-12-31 | $-0.63 | $-0.53 |
| 2022-11-10 | 2022-09-30 | $-0.56 | $-0.58 |
| 2022-08-10 | 2022-06-30 | $-0.68 | $-0.61 |
| 2022-05-12 | 2022-03-31 | $-0.71 | $-0.64 |
| 2022-03-30 | 2021-12-31 | $-0.66 | $-0.73 |
| 2021-11-09 | 2021-09-30 | $-0.63 | $-0.63 |
| 2021-08-12 | 2021-06-30 | $-0.38 | $-0.64 |
| 2021-05-13 | 2021-03-31 | $-0.64 | $-0.86 |
| 2021-03-31 | 2020-12-31 | $-0.72 | $-7.95 |